NICE scraps age limit for treatment of bedwetting

Children under the age of seven should now be considered for treatment for bedwetting, according to NICE guidance.

Children under seven can now be offered treatment for bedwetting (Photograph: SPL)
Children under seven can now be offered treatment for bedwetting (Photograph: SPL)

However, in separate advice, the institute rejected the asthma drug omalizumab (Xolair) for children under the age of 12 in the NHS in England.

In its guidance, NICE said more than a fifth of children aged four and five regularly wet the bed, but practices have traditionally only offered treatment from the age of seven. This latest guidance, the first to address nocturnal enuresis, removes the minimum age for management of the condition.

NICE deputy chairman Dr Gillian Leng said: 'Our clinical guideline does not specify a minimum age limit. This means that for the first time advice or treatments will be available to children under seven years, who may have previously been excluded from these services.'

NICE said GPs and practice nurses should inform children and parents that positive rewards for agreed behaviour, like going to the toilet before bed, rather than dry nights, should be used either alone or in conjunction with other treatments for bedwetting.

The use of an alarm is suggested as a first-line treatment, unless an alarm is considered undesirable to the child or parents, or if the child has infrequent bedwetting.

NICE has said the asthma drug omalizumab should be used for some over-12s, but that evidence for use in younger children suggested it offered limited benefits over other treatments. But the guidance states that children currently receiving omalizumab should be able to continue with it until it is considered appropriate to stop.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...

GPonline's news editor wins medical journalism award

GPonline's news editor wins medical journalism award

GPonline news editor Nick Bostock has won News Story of the Year (specialist media)...

How GPs can support patients with 'long COVID'

How GPs can support patients with 'long COVID'

GPs must be ready to support patients with physical, psychological and social problems...

BMA demands 'rule of six' overhaul to prevent further lockdowns

BMA demands 'rule of six' overhaul to prevent further lockdowns

The government must scrap its high-risk ‘rule of six’ and introduce more stringent...